These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6332798)

  • 21. Predictors of coronary bypass grafting in a population of middle-aged men.
    Dudas KA; Wilhelmsen L; Rosengren A
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):122-7. PubMed ID: 17301637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary prevention of ischemic heart disease].
    Kruglov VA
    Med Sestra; 1987 Jul; 46(7):12-6. PubMed ID: 3657467
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of physical activity on coronary heart disease].
    Aigner A
    Wien Med Wochenschr; 1984 Jan; 134(1):5-9. PubMed ID: 6719931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of cardio-vascular diseases.
    Lequime J; Kornitzer M
    Indian Heart J; 1972 Apr; 24(2):74-86. PubMed ID: 4564877
    [No Abstract]   [Full Text] [Related]  

  • 25. [Objectives of some experiences with population studies of ischemic heart disease].
    Nieveen J; May JF
    Ned Tijdschr Geneeskd; 1971 Oct; 115(42):1773-6. PubMed ID: 4946675
    [No Abstract]   [Full Text] [Related]  

  • 26. Exercise and coronary heart disease: role in primary prevention.
    Cantwell JD
    Heart Lung; 1984 Jan; 13(1):6-13. PubMed ID: 6559187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of smoking cessation, physical training and psychological interventions in secondary prevention of coronary heart disease].
    Jost S
    Z Kardiol; 1994 Oct; 83(10):742-58. PubMed ID: 7810188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
    Gysan DB
    Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of coronary heart disease.
    World Health Organ Tech Rep Ser; 1982; 678():1-53. PubMed ID: 6812294
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pro and contra: prevention of coronary heart diseases].
    Meijler FL
    Ned Tijdschr Geneeskd; 1978 Feb; 122(8):261-2. PubMed ID: 628460
    [No Abstract]   [Full Text] [Related]  

  • 34. Focus on prevention.
    Oka B
    Can Nurse; 1976 Sep; 72(9):17-9. PubMed ID: 963680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary risk factors 6-12 months after coronary artery bypass grafting. Comparison of surveys in 1986, 1990 and 1994.
    Simons LA; Simons J; Parfitt A
    Med J Aust; 1994 Nov; 161(9):536-7. PubMed ID: 7968753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death.
    Zotz RB; Klein M; Dauben HP; Moser C; Gams E; Scharf RE
    Thromb Haemost; 2000 Mar; 83(3):404-7. PubMed ID: 10744144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of heart disease in the asymptomatic post infarction patient.
    Schoenberger JA
    Prim Care; 1977 Jun; 4(2):217-23. PubMed ID: 586713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Stress and heart disease.
    Med J Aust; 1974 Jan; 1(4):85-6. PubMed ID: 4816069
    [No Abstract]   [Full Text] [Related]  

  • 39. Health knowledge and community prevention of coronary heart disease.
    Puska P; Vienola P; Kottke TE; Salonen JT; Neittaanmäki L
    Int J Health Educ; 1981; 24(2 Suppl):1-11. PubMed ID: 7257612
    [No Abstract]   [Full Text] [Related]  

  • 40. Trends in coronary heart disease mortality and associated risk factors in New Zealand.
    Beaglehole R; Hay DR; Foster FH; Sharpe DN
    N Z Med J; 1981 Jun; 93(685):371-5. PubMed ID: 6942306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.